CA2501751C - Therapie combinee des infections au vih - Google Patents

Therapie combinee des infections au vih Download PDF

Info

Publication number
CA2501751C
CA2501751C CA2501751A CA2501751A CA2501751C CA 2501751 C CA2501751 C CA 2501751C CA 2501751 A CA2501751 A CA 2501751A CA 2501751 A CA2501751 A CA 2501751A CA 2501751 C CA2501751 C CA 2501751C
Authority
CA
Canada
Prior art keywords
product
grams
hiv
aids
micron filter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2501751A
Other languages
English (en)
Other versions
CA2501751A1 (fr
Inventor
Shalom Z. Hirschman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OHR Pharmaceutical Inc
Original Assignee
OHR Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OHR Pharmaceutical Inc filed Critical OHR Pharmaceutical Inc
Priority claimed from CA002285463A external-priority patent/CA2285463C/fr
Publication of CA2501751A1 publication Critical patent/CA2501751A1/fr
Application granted granted Critical
Publication of CA2501751C publication Critical patent/CA2501751C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2501751A 1997-04-15 1998-04-15 Therapie combinee des infections au vih Expired - Fee Related CA2501751C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US83964997A 1997-04-15 1997-04-15
US08/839,649 1997-04-15
US92288897A 1997-09-03 1997-09-03
US08/922,888 1997-09-03
CA002285463A CA2285463C (fr) 1997-04-15 1998-04-15 Therapie combinee des infections au vih

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002285463A Division CA2285463C (fr) 1997-04-15 1998-04-15 Therapie combinee des infections au vih

Publications (2)

Publication Number Publication Date
CA2501751A1 CA2501751A1 (fr) 1998-10-22
CA2501751C true CA2501751C (fr) 2011-09-27

Family

ID=34623368

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2501751A Expired - Fee Related CA2501751C (fr) 1997-04-15 1998-04-15 Therapie combinee des infections au vih

Country Status (1)

Country Link
CA (1) CA2501751C (fr)

Also Published As

Publication number Publication date
CA2501751A1 (fr) 1998-10-22

Similar Documents

Publication Publication Date Title
JP3246918B2 (ja) 感染症の治療のためのＩＬ―１２およびＩＦＮαの使用
US9050314B2 (en) Methods of treatment of arthritis using thymus-derived compositions
AU748594B2 (en) A combination therapy for HIV infections
RU2388485C2 (ru) Стимулятор секреции глюкагон-подобного пептида 1, продукты питания или напитки, стимулирующие секрецию глюкагон-подобного пептида 1, ингибитор постпрандиальной гипергликемии и продукты питания или напитки, ингибирующие постпрандиальную гипергликемию
EP0584558A2 (fr) Composition pour supprimer l'infection et la croissance du virus de l'immunodéficience humaine en utilisant une protéine fixant le fer
EP0357958B1 (fr) Préparation pharmaceutique pour le traitement de maladies à virus comprenant un extrait de foie
CA2501751C (fr) Therapie combinee des infections au vih
WO1994013314A1 (fr) Traitement combine des infections a vih mettant en oeuvre la thymosine, l'interleukine et des inhibiteurs de replication du vih ou de transcriptase reverse
KR100694011B1 (ko) 다발성 경화증의 샤페로닌 10 및 베타-인터페론 치료법
MXPA99009518A (en) A combination therapy for hiv infections
US20010006682A1 (en) Method for treating patients with suppressed immune systems
AU2017330451B2 (en) Apoaequorin and vitamin D-containing compositions and methods of using same
US4529543A (en) Hepatosin
WO2005079269A2 (fr) Methode de traitement de carcinome
Saharan Paradigm shift in discovery & secretion of Biosimilars via path breaking innovation
EP0058857B1 (fr) Hépatosine, procédé de préparation et composition thérapeutique contenant l'hépatosine
Saharan Health for All
KR20210130425A (ko) 대장균 부착 단백질 FimH를 유효성분으로 포함하는 항암 면역 증강용 조성물
JPH05505194A (ja) リンパ系細胞の再生促進剤
Harrer et al. Intralymphatic interleukin-2 in combination with zidovudine for the therapy of patients with AIDS
Meyer et al. Treatment of pernicious anemia with animal protein concentrates of bacterial origin
Walker The Legacy of Carson B. Burgstiner, MD: Thymus Gland Reactivation to Overcome the Symptoms
Schnittman Treatment of HIV‐1 Infection with Combination Therapy: Antiretroviral Agents and Biological Response Modifiers
EP0360191A2 (fr) Composition active contre le virus du sida
HU203971B (en) Process for producing synergetic combination pharmaceutical compositions comprising 3'-azido-3'-deoxythymidine and one more active ingredient

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160415